• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

FDA approval

human brain abstract art
MedTech

After 20 years, Medtronic claims neurostim approval in dystonia

Medtronic said it finally has the clinical data for its approach, making its stimulators the first to carry a U.S. label for the movement disorder.
Conor Hale Dec 4, 2025 10:25am
A baby inside of an incubator

Ceribell nets FDA nod for detecting seizures in preterm newborns

Nov 26, 2025 9:49am
breast cancer mammogram

IceCure nabs FDA OK for breast cancer cryoablation treatment

Oct 6, 2025 9:00am
heart model

FDA approves Kardium’s Globe pulsed field ablation catheter

Sep 3, 2025 11:00am
Cartoon of businessmen standing around a broken target

Outlook lays off 23% of staff as it eyes FDA approval, EU debut

Dec 16, 2024 8:25am
Abbott Espirit BTK

FDA approves Abbott dissolving stent for arteries below the knee

Apr 29, 2024 9:54am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings